This is a preprint.
Protein Kinase C δ: a critical hub regulating macrophage immunomodulatory functions during Mycobacterium tuberculosis infection
- PMID: 40475622
- PMCID: PMC12139767
- DOI: 10.1101/2025.05.19.653976
Protein Kinase C δ: a critical hub regulating macrophage immunomodulatory functions during Mycobacterium tuberculosis infection
Abstract
A host-modulating candidate gene involved in putative pathogen-killing pathways, with potential novel therapeutic intervention, Protein Kinase C - δ (PKCδ) has been recognized as a critical marker of inflammation with clinical and experimental evidence in recent years. Pulmonary microenvironment during Mtb infection is largely governed by lung resident macrophages, initiating innate and subsequent adaptive immune responses. We investigated the role of PKCδ in macrophages using a macrophage-specific PKCδ knockout mice model (LysMcrePKCδflox/flox). PKCδ deficiency in macrophages triggers an early lymphocytic immune response, increases neutrophil recruitment, and reduces inflammatory macrophages in the lungs, leading to higher Mtb burden and exacerbated pathology. Experimental and omics analysis further revealed that dysregulation of antimicrobial effector functions is detrimental to macrophage's ability to restrict bacterial growth in vitro. Importantly this defect was mitigated by exogenous GM-CSF supplementation and/or overexpressing PKCδ in macrophages. Thus, PKCδ plays a crucial role in immune modulation during Mtb infection with GM-CSF amongst several downstream pathways through which PKCδ exerts its regulatory effects.
Conflict of interest statement
Competing interests: All other authors declare they have no competing interests.
Figures
References
-
- W. H. Organization, Global tuberculosis report 2023. (World Health Organization, 2023).
-
- Guler R., Brombacher F., Host-directed drug therapy for tuberculosis. Nat Chem Biol 11, 748–751 (2015). - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources